This page shows information from a previous legislative session and is presented for archive purposes only.

HR1012 - TO ENCOURAGE THE UNITED STATES CONGRESS TO INVESTIGATE THE INCREASES IN COST OF GENERIC PRESCRIPTION MEDICATIONS; AND TO URGE THE FOOD AND DRUG ADMINISTRATION TO REVIEW FEDERAL REGULATIONS CONCERNING GENERIC PHARMACEUTICAL MANUFACTURERS.


Bill Number:
HR1012 PDF
HR1012
Status:
House -- WITHDRAWN BY AUTHOR
Originating Chamber:
House
Lead Sponsor:
CoSponsors:
Introduction Date:
2/5/2015 5:06:00 PM

Upcoming Events

No upcoming events for this bill.


Bill Status History

Chamber Date Action Vote
Chamber: House Date: 2/10/2015 8:33:43 AM WITHDRAWN BY AUTHOR
Chamber: House Date: 2/6/2015 10:29:19 AM Read the first time, rules suspended, read the second time and referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE
Chamber: House Date: 2/5/2015 5:06:00 PM Filed